Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effective dose of alfentanil combined with propofol for gastroscopy anesthesia
ChiCTR2200063245Phase 4Not yet recruiting
- Sponsor
- The Seventh Affiliated Hospital of Southern Medical University
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of propofol and alfentanil in gastritis, sponsored by The Seventh Affiliated Hospital of Southern Medical University. Primary endpoint: Half effective dose (ED50) of propofol + alfentanil for gastroscopy anesthesia. Planned start Sep 2022; status: not yet recruiting.
02
Drugs
propofolalfentanil
03
Conditions
gastritis
Beyond the preview
Go deeper on ChiCTR2200063245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063245.